What is the Hologic Mammography Market Size?
The global hologic mammography market size accounted for USD 3.32 billion in 2025 and is predicted to increase from USD 3.66 billion in 2026 to approximately USD 8.82 billion by 2035, expanding at a CAGR of 10.26% from 2026 to 2035. The market is expanding due to the increasing breast cancer rates and technological advancements to detect breast cancer at an initial stage owing to the increased awareness about preventive healthcare measures.
Market Highlights
- North America dominated global industry and held the largest market share in 2025.
- The Asia Pacific is projected to grow at the fastest CAGR from 2026 to 2035.
- By technology, the digital mammography segment held the largest market share in 2025.
- By technology, the digital breast tomosynthesis segment is set to grow at the fastest-growing CAGR in 2025.
- By product type, the mammography systems segment held the largest market share in 2025.
- By product type, the biopsy system segment is projected to grow at the fastest CAGR between 2026 and 2035.
- By end user, the hospitals segment held the largest market share in 2025.
- By end user, the diagnostic imaging center segment is projected to grow at the fastest CAGR from 2026 to 2035.
Hologic Mammography Market: A Benchmark set for Mammography
The mammography market is rapidly evolving through the integration of AI-assisted diagnostics and value-based care models that emphasize early detection, diagnostic accuracy, and improved patient outcomes. As a leader in women's health imaging, Hologic offers a comprehensive portfolio ranging from full-field digital mammography to digital breast tomosynthesis and contrast-enhanced mammography systems. These technologies are designed to improve lesion visualization, particularly in dense breast tissue, support earlier disease detection, and enable more precise risk stratification, allowing clinicians to tailor follow-up and treatment pathways for high-risk patients.
Continuous innovation in low-dose imaging, workflow efficiency, and image clarity is setting new benchmarks across the market. Advanced systems such as the Genius 3D Mammography exam from Hologic have been widely adopted for their ability to enhance cancer detection rates while maintaining manageable radiation exposure and streamlined clinical workflows. In parallel, platforms like the Mammomat B.brilliant from Siemens Healthineers are contributing to market advancement through low-dose acquisition technologies and AI-supported image reconstruction. Together, these innovations are reinforcing a shift toward more accurate, efficient, and patient-centric breast imaging without concluding or limiting future technological evolution.
AI Shifts in Hologic Mammography Market
By recognizing the clinical significance of AI in breast imaging, Hologic has developed and launched its Genius AI Detection solution, supported by extensive clinical studies using 3D mammography screening exams. These studies evaluated whether AI-generated detection scores correlate with tumor characteristics such as histologic grade and lymph node involvement. The research was conducted exclusively on biopsy-proven cancer cases, and the findings demonstrated high analytical precision, with AI showing stronger detection signals in higher-grade tumors and node-positive cancers, which are typically associated with more aggressive disease profiles.
Evidence indicates that AI-based detection systems can achieve performance levels comparable to experienced radiologists, particularly in identifying clinically significant cancers with high sensitivity. Rather than replacing clinicians, AI is increasingly positioned as a decision-support tool that enhances radiologist confidence, reduces oversight risk, and improves consistency in image interpretation. By highlighting subtle imaging features that may be difficult to detect in complex or dense breast tissue, AI-assisted mammography supports earlier diagnosis and more accurate clinical assessment, strengthening its role in modern, value-based breast cancer screening workflows.
Hologic Mammography Market Outlook
- Industry growth overview: The global Hologic mammography market is observing a significant growth rate due to the growing awareness of early detection of breast cancer with the help of technologies like AI and 3D imaging, along with the government screening programs and incentives for it to spread healthcare awareness. A key driving factor includes the increasing shift from conventional 2D to highly developed 3D digital breast tomosynthesis systems to acquire superior accuracy and better outcomes.
- Major Investors: The market is consolidated with the broad base of institutional investors like the vanguard group,Inc, T. Rowe Price Group, Inc., Blackrock Inc., and others. Hologic recently announced their acquisition and definitive agreement by funds supported by Blackstone and TPG, highlighting significant shifts in ownership.
- Startup Ecosystem: A startup ecosystem for the hologic mammography market is flourishing notably and focused on developing software solutions with the help of AI and other technologies to enhance capabilities of existing systems. Hologic itself collaborated with its international partner, Bayer, aiming to advance contrast-enhanced mammography adoption, and launched its own FDA-supported Genius AI detection technology.
Market Scope
| Report Coverage | Details |
| Market Size in 2025 | USD 3.32 Billion |
| Market Size in 2026 | USD 3.66 Billion |
| Market Size by 2035 | USD 8.82 Billion |
| Market Growth Rate from 2026 to 2035 | CAGR of 10.26% |
| Dominating Region | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
| Segments Covered | Technology, Product Type, End User, and Region |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Segmental Insights
Technology Insights
Why Is Digital Mammography Preferred in the Hologic Mammography Market?
The digital mammography segment held the largest market share in 2025, due to the offerings of this technology, like advanced 3D mammography, seamless AI integration, and comfortable features for patients like SmartPaddle, which helps improve accuracy by reducing recalls. Digital mammography uses significantly less radiation than traditional film-based methods, making it much safer for screening tests for breast cancer.
The digital breast tomosynthesis segment was set to grow at the fastest CAGR during the forecasted period due to significantly improved accuracy in breast cancer detection using three-dimensional imaging that reduces tissue overlap and lowers false-positive rates. Wider clinical adoption is also being supported by growing reimbursement acceptance and its increasing use in routine screening for women with dense breast tissue. In addition, integration with AI-based image analysis tools is further improving radiologist confidence and diagnostic consistency without increasing invasiveness.
Product Type Insights
Why are Mammography systems dominating in the Hologic Mammography Market?
The mammography systems segment held the largest market share in 2025, due to the superior 3D image offerings with FDA approval, especially for dense breasts, which assist in detecting more invasive cancers without compromising on the patient's comfort. Its high-resolution imaging and lower radiation dose are another key driver of the segment's growth on a large scale.
The biopsy system segment is projected to grow at the fastest CAGR during the foreseeable period, due to its offerings like minimum invasion and highly precise tissue sampling for lesions that are suspicious as cancerous and helps screening mammography machines to work as a biopsy tool. Systems such as Affirm Upright can easily be added to existing Hologic mammography units, which is another driving factor for the segment.
End User Insights
Why Do Hospitals Find Extensive Applications in the Hologic Mammography Market?
The hospitals segment held the largest market share in 2025. The segment is dominating, as many hospitals are extensively using Hologic mammography systems owing to their FDA approved performance in finding breast cancer along with the features that are specifically tailored for operational efficiency and increased patient comfort. Also, Hologic provides an integrated platform that includes screening and diagnostic tools along with capabilities like image-guided biopsy. Software like Contrast-enhanced mammography allows hospitals to manage the entire breast health continuum of care from a single trusted provider.
The diagnostic imaging center segment is projected to grow at the fastest CAGR during the foreseeable period. The segment is largely growing due to the focus of diagnostics centers on offering patient-centric treatments with high-level comfort without compromising test accuracy. Rapid 3D scan times and features like C-view software can generate 2D images from 3D views and reduce the need for X-ray exposure and high radiation dosage.
Regional Insights
What Factors Made North America a Dominant Region in the Hologic Mammography Market?
North America held the largest share in the Hologic mammography market during 2025, driven by rising breast cancer incidence and high awareness of preventive screening practices. Government-supported adoption of advanced imaging technologies, including digital mammography and digital breast tomosynthesis, has enabled large-scale deployment across healthcare systems. Public health initiatives and screening guidelines continue to encourage routine mammography, supporting consistent utilization of advanced breast imaging systems in both public and private care settings.
The region benefits from a highly developed network of hospitals, outpatient imaging centers, and specialized diagnostic clinics staffed by trained radiologists and breast imaging specialists. Strong participation from patient advocacy organizations and screening programs has contributed to high screening volumes and earlier detection, improving clinical outcomes and reinforcing demand for advanced mammography platforms from hologic across North America.
U.S. Hologic Mammography Market Trends
Hologic is headquartered in the U.S. and leverages local networks of diagnostic imaging centers, hospitals, and breast cancer care centers backed by government funding. A significant investment in research and development and strategic partnerships allows companies to establish and launch innovative products and solutions quickly. The U.S. is further benefitted from, and advanced by, health infrastructure that supports Hologic mammography and its easy integration with the existing infrastructure.
What Reasons Fuel Asia Pacific Hologic Mammography Market's Growth?
Asia Pacific is projected to grow at the fastest CAGR during the period 2026–2035, supported by rising awareness of preventive breast cancer screening and steadily increasing incidence rates across urban populations. Governments across the region are actively promoting early diagnosis through public healthcare reforms and targeted funding for advanced imaging technologies, including digital mammography and 3D breast tomosynthesis. Rapid expansion of private hospitals, diagnostic chains, and specialty imaging centers in major cities is accelerating adoption of digital and AI-enabled mammography systems to improve diagnostic accuracy and screening throughput.
In parallel, strong involvement from government health departments and non-governmental organizations focused on women's health is reinforcing screening participation and institutional adoption. Large-scale awareness campaigns, subsidized screening programs, and national cancer control initiatives are encouraging hospitals and diagnostic centers to deploy advanced mammography platforms from providers such as Hologic. These efforts are particularly impactful in densely populated urban corridors, where healthcare providers are under pressure to reduce late-stage diagnoses and improve clinical outcomes through earlier, technology-enabled detection pathways.
China Hologic Mammography Market Analysis
The China hologic mammography market is largely dominated by the transition from analog imaging systems to digitalization, with advanced imaging technologies showcasing the nation's transforming healthcare modernization programs. A key driver includes the integration of AI/ML for excellent diagnostic support, remarkable manufacturing capabilities, and the rise of local players that offer innovative diagnostic solutions for enhanced imaging along with dedicated breast cancer care centers.
What are the Key Drivers of the Europe Hologic Mammography Market?
The European Hologic mammography market is experiencing accelerated growth due to a combination of epidemiological pressure and system-level healthcare responses. Rising breast cancer incidence remains a central driver, with an estimated 116,000 new cases reported annually across Europe, reinforcing the clinical need for accurate, early-stage detection technologies. This disease burden is increasing demand for advanced mammography solutions, particularly digital breast tomosynthesis and AI-assisted imaging systems that improve lesion visibility and diagnostic confidence in dense breast tissue across screening and diagnostic settings.
In response, European Union health authorities and national healthcare systems are increasingly supporting the adoption of advanced mammography technologies from providers such as Hologic as part of standardized breast cancer screening and diagnostic pathways. Streamlined regulatory approvals, evolving reimbursement frameworks, and alignment with EU-wide cancer control strategies are facilitating broader deployment of these systems. At the same time, growing capital inflows from private equity, alongside strategic partnerships between imaging providers, hospital networks, and diagnostic chains, are strengthening infrastructure investment and supporting sustained long-term growth of advanced mammography adoption across Europe.
Germany Hologic Mammography Market Trends
The market is rapidly growing as Germany recorded more than 74,000 new breast cancer cases in 2022, highlighting the emergency to treat breast cancer in Germany. This has fueled the expansion of the national screening program for women aged 70-75 in Germany and further consolidated demand for Hologic mammography in the region. Also, the hybrid-DRG model has been introduced by the government in 2024 that simplifies billing for advanced imaging and supports clear economic results for the purchase of digital breast tomosynthesis, propelling the market's growth further.
Which Factors Support Expansion of the Middle East & Africa Hologic Mammography Market?
The Middle East and Africa are showing prominent growth in the Hologic mammography market, primarily driven by a steadily increasing geriatric population that is more susceptible to chronic diseases, including breast cancer. Breast cancer is reported as one of the most prevalent cancers among women across several Middle Eastern and African countries, increasing the urgency for accessible and accurate screening solutions. Late-stage diagnosis remains a challenge in many parts of the region, which is reinforcing the importance of expanding early detection infrastructure through modern mammography systems.
In parallel, accelerated healthcare development and digital transformation initiatives are strengthening market momentum. Governments and private healthcare providers are investing in diagnostic imaging infrastructure, digital hospitals, and oncology-focused care pathways, which is supporting adoption of advanced mammography technologies from providers such as Hologic. Rapid digitalization of imaging workflows, combined with growing awareness campaigns and expanding access to specialized diagnostic centers, is increasing utilization of mammography systems across urban healthcare hubs in the Middle East and Africa.
UAE Hologic Mammography Market Trends
The UAE Hologic mammography market is witnessing notable momentum driven by the frequent introduction of technologically advanced breast imaging systems aimed at improving early cancer detection. Healthcare providers in the United Arab Emirates are increasingly adopting digital mammography, digital breast tomosynthesis, and AI-supported imaging platforms to enhance diagnostic accuracy and workflow efficiency. These investments are aligned with national healthcare modernization initiatives and the expanding role of advanced radiological methods across public hospitals, private diagnostic chains, and specialized women's health centers.
In parallel, women in the UAE are demonstrating a progressively positive attitude toward preventive breast cancer screening, supported by rising health awareness and improved access to diagnostic services. Demand is being reinforced by calls for more structured awareness campaigns, wider screening coverage, and access to advanced technologies offered by providers such as Hologic. Healthcare authorities, NGOs, and private providers are expanding outreach programs and screening initiatives, which is encouraging higher participation rates and increasing utilization of advanced mammography systems across urban healthcare settings.
Hologic Mammography Market Value Chain Analysis
Who are the Major Players in the Global Hologic Mammography Market?
The major players in the hologic mammography market include GE Healthcare, Hologic Inc., Siemens Healthineers, Philips Healthcare, Fujifilm Holdings Corporation, Canon Medical Systems Corporation, Carestream Health Inc., Planmed Oy, Metaltronica SpA, Konica Minolta Inc., Aurora Imaging Technologies Inc., Dilon Technologies Inc., SonoCine Inc., Seno Medical Instruments Inc., Delphinus Medical Technologies Inc., IM3/S I.M.S. Srl, Christie Innomed, General Medical Merate S.p.A., Analogic Corporation, and NovaRad.
Recent Developments
- In December 2025, Hologic Inc. unveiled new data that shows how the company's advanced AI-based mammography solution can facilitate the detection of more breast cancers based on a retrospective analysis of 7,500 digital breast tomosynthesis screening exams via Hologic's Genius AI detection solution.(Source: https://www.marketscreener.com)
- In January 2025, Siemens Healthineers Announces their firsts Installation of the Mammomat B.brilliant Mammography System in the U.S. with new 3D image acquisition and reconstruction technology providing the fastest tomosynthesis of 50 degrees in just 5 seconds.(Source: https://www.siemens-healthineers.com)
Segments Covered in the Report
By Technology
- Digital Mammography (2D)
- Digital Breast Tomosynthesis (3D)
- Contrast-Enhanced Mammography
- AI Enhanced Systems
By Product Type
- Mammography Systems
- Biopsy Systems
- Workstations & Software
- Accessories & Detectors
By End User
- Hospitals
- Diagnostic Imaging Centers
- Breast Care Clinics & Specialized Oncology Centers
- Academic & Research Institutes
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
Frequently Asked Questions
Ask For Sample
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
sales@precedenceresearch.com
+1 804-441-9344